Exopharm

Melbourne, AU
Exosome
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29
56.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Exopharm

Signal Score
56.5/100 (as of 2026-04-29)
Quality Compliance
Assessment pending
Headquarters
Melbourne, AU
Modalities
Exosome
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Exopharm

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesExosome
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 53.0
1 manufacturing site: Melbourne, AU
Modalities: Exosome
Capacity assessment: 53.0/100
Sites: Melbourne, AU
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Melbourne, AU
Modalities: Exosome
Capacity assessment: 53.0/100

Frequently Asked Questions About Exopharm

What is Exopharm's CDMO Signal Score?
Exopharm has a Signal Score of 56/100, based on quality, operations, financial stability, and capacity data.
Evaluating Exopharm for a manufacturing program?
Use the free AI matchmaker to compare Exopharm against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Exosome CDMOs →

Similar CDMOs

Codiak BioSciences (Sarepta)
Cambridge, MA
Signal Score: 78.0
Exosome
Esco Aster
Singapore, SG
Signal Score: 63.0
Cell Therapy, Exosome
CoJourney Inc.
Ambler, PA (US operations; primary manufacturing in Hangzhou, Zhejiang, China)
Signal Score: 60.0
Plasmid DNA, AAV, Adenoviral, Lentiviral, Retroviral, mRNA, sgRNA, Exosome
Evox Therapeutics
Oxford, UK
Signal Score: 57.5
Exosome
ExoXpert (EXO Biologics)
Liege, BE
Signal Score: 56.5
Exosome